#1 Clinical Trials Search in Europe

Find a Clinical Trial

Search Trials by Disease

Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
Rare Diseases Treatments

Search Trials by Disease

Ovarian cancer stage IV T-cell lymphoma Primary mediastinal large B-cell lymphoma Acute lymphocytic leukaemia Hepatic angiosarcoma Duchenne muscular dystrophy Bronchopulmonary aspergillosis Neuroendocrine tumour Progressive supranuclear palsy Subarachnoid haemorrhage Oesophageal adenocarcinoma stage III Still's disease Cushing's syndrome Retinopathy proliferative Uterine leiomyosarcoma More trials…
Learn about Rare Diseases

Haemophilia B with anti factor IX – Treatment Pemphigus – Treatment Pituitary-dependent Cushing’s syndrome – Trials in Disease Angiosarcoma – Treatment Undifferentiated sarcoma – Diagnostics Alagille syndrome – Trials in Disease Mastocytosis Alexander disease – Diagnostics Chordoma – Trials in Disease Propionic acidaemia – Trials in Disease More diseases
Vaccine Clinical Trials
Pediatric Clinical Trials
Resources for Patients

Browse Innovative Treatments

NADOFARAGENE FIRADENOVEC Pd01B STREPTOCOCCUS PYOGENES SC0062 Capsaicin VOROLANIB GS-4321 Dimethyl Fumarate Darunavir Follitropin Beta Daxdilimab Cyclophosphamide PARECOXIB Ceftazidime Pentahydrate Folic Acid, Anhydrous Telmisartan Trametinib Dimethyl Sulfoxide Iph6501 Vitamin A Bp Hydrocortisone Ph. Eur. More therapies…

Learn about Your Condition

Primary hypercholesterolaemia Sciatica PIK3CA-activated mutation Congenital aplastic anaemia Colonoscopy Malignant melanoma stage II Fabry's disease Shock Erdheim-Chester disease Encephalitis Japanese B Cystic fibrosis lung Obstructive pancreatitis Keratosis follicular Combined immunodeficiency Hairy cell leukaemia recurrent More diseases
Healthy Volunteers
Patient Guide
Our Partners
About Us
Contact us
Region

🇪🇺 Europe
🇦🇹 Austria
🇭🇷 Croatia
🇨🇿 Czech Republic
🇩🇰 Denmark
🇪🇪 Estonia
🇫🇮 Finland
🇫🇷 France
🇩🇪 Germany
🇮🇸 Iceland
🇮🇹 Italy
🇱🇻 Latvia
🇱🇹 Lithuania
🇳🇱 Netherlands
🇳🇴 Norway
🇵🇱 Poland
🇵🇹 Portugal
🇷🇴 Romania
🇸🇰 Slovakia
🇸🇮 Slovenia
🇪🇸 Spain
🇸🇪 Sweden

Incontinence

Study on Solifenacin, Mirabegron, and Their Combination for Treating Overactive Bladder and Daytime Urinary Incontinence in Children Aged 5 to 14 Years

Recruiting

3 1 1 1
Investigated Diseases:
- Incontinence
- Urinary incontinence
Investigated Drugs:
- Mirabegron
- Solifenacin Succinate
Study on Stopping Solifenacin and Mirabegron for Children with Daytime Urinary Incontinence

Not recruiting

3 1 1 1
Investigated Diseases:
- Incontinence
- Urinary incontinence
Investigated Drugs:
- Mirabegron
- Solifenacin Succinate

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

Incontinence

Study on Solifenacin, Mirabegron, and Their Combination for Treating Overactive Bladder and Daytime Urinary Incontinence in Children Aged 5 to 14 Years

Study on Stopping Solifenacin and Mirabegron for Children with Daytime Urinary Incontinence

Investigational Drugs in This Location

Medical Conditions Being Studied in This Location

We use cookies